Boer Katalin, Helinger Eva, Helinger Andrea, Pocza Peter, Pos Zoltan, Demeter Pal, Baranyai Zsolt, Dede Kristof, Darvas Zsuzsanna, Falus Andras
Department of Genetics, Cell and Immunobiology, Semmelweis University, Nagyvárad tér. 4, 1089 Budapest, Hungary.
Eur J Cell Biol. 2008 Apr;87(4):227-36. doi: 10.1016/j.ejcb.2007.12.003. Epub 2008 Feb 6.
Production of histamine in colon tumours has been described earlier. Histamine-mediated signals have been shown to be implicated in tumour growth, and the effects of histamine are largely determined locally by the histamine receptor expression pattern. We analysed histamine receptor expression in human colorectal cancer, adenoma and normal mucosa by quantitative reverse transcription-polymerase chain reaction (RT-PCR), Western blot analysis and immunostaining. Real-time RT-PCR results revealed significantly decreased (p<0.001) H1R and H4R mRNA levels in tumours compared to normal colonic mucosa, without any significant change in H2R mRNA expression. H3R was absent in most samples; it was detected at low levels in 7.9% of the cases. Protein analysis showed a similar decrease in histamine receptor expression in carcinoma and adenoma compared to normal mucosa controls. Based on these results, we performed further Western blot analysis on Dukes-classified and -selected tumour samples. We found significantly decreased H4R levels in neoplastic samples compared to normal colonic tissue, but there was no significant correlation between histamine receptor expression profile and the Dukes stage of tumours. Immunohistochemical staining revealed expression patterns of H1R, H2R and H4R similar to those suggested by the mRNA and Western blot results. In the present study, we demonstrate that H1R, H2R and H4R are expressed in colon carcinoma and the adjacent normal mucosa. The results suggest a dramatic alteration in the distribution of histamine receptors in colon cancer. These findings raise the perspective of targeted pharmacological studies with selective histamine receptor antagonists or agonists in the therapy of colorectal tumours.
结肠肿瘤中组胺的产生此前已有描述。组胺介导的信号已被证明与肿瘤生长有关,组胺的作用在很大程度上由局部组胺受体表达模式决定。我们通过定量逆转录-聚合酶链反应(RT-PCR)、蛋白质印迹分析和免疫染色分析了人结直肠癌、腺瘤和正常黏膜中组胺受体的表达。实时RT-PCR结果显示,与正常结肠黏膜相比,肿瘤中H1R和H4R mRNA水平显著降低(p<0.001),而H2R mRNA表达无显著变化。大多数样本中未检测到H3R;仅在7.9%的病例中检测到低水平表达。蛋白质分析显示,与正常黏膜对照相比,癌组织和腺瘤中组胺受体表达也有类似程度的降低。基于这些结果,我们对按杜克分期分类并选取的肿瘤样本进一步进行了蛋白质印迹分析。我们发现,与正常结肠组织相比,肿瘤样本中H4R水平显著降低,但组胺受体表达谱与肿瘤的杜克分期之间无显著相关性。免疫组织化学染色显示H1R、H2R和H4R的表达模式与mRNA和蛋白质印迹结果所示相似。在本研究中,我们证明H1R、H2R和H4R在结肠癌及相邻正常黏膜中均有表达。结果提示结肠癌中组胺受体分布发生了显著改变。这些发现为在结直肠癌治疗中使用选择性组胺受体拮抗剂或激动剂进行靶向药理学研究提供了前景。